The Real Message Behind Commercial mRNA Products eBook
Read the article:
Learning to Think at Lightspeed
Read the eBook:
Pharmaceutical Technology’s The Real Message Behind Commercial mRNA Products eBook
CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Learning to Think at Lightspeed
Published on:
Chris Spivey
Pharmaceutical Technology, The Real Message Behind Commercial mRNA Products, April 2023 eBook, Volume 2023 eBook, Issue 3
Pages: 6–11
Actions combatting the next pandemic must be diverse, reliable, and sustainable.
World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the United States’ goal to design, test, and review a new vaccine just 100 days after a pandemic declaration and to produce enough vaccines for the US and the world in 130 and 200 days. Past preparedness efforts have focused on innovation and reliability—culminating in the novel mRNA vaccines. Today, it’s important to consider diverse responses—and how the industry can make investments sustainable and “ready” for when an emergency happens.
Advertisement
Read this article in Pharmaceutical Technology’s The Real Message Behind Commercial mRNA Products eBook
About the author
Chris Spivey is editorial director of Pharmaceutical Technology.
Article details
Pharmaceutical Technology
eBook: The Real Message Behind Commercial mRNA Products
April 2023
Pages: 6–11
Citation
When referring to this article, please cite it as Spivey, C. Learning to Think at Lightspeed. Pharmaceutical Technology's The Real Message Behind Commercial mRNA Products eBook (April 2023).
Related Content:
